DSP Healthcare Fund · Regular · Growth
NAV
₹44.4120
as of 15 Jul 2026
Expense Ratio
1.94%
AUM
₹2,990 Cr
Lumpsum returns (CAGR)
- 1Y
- +10.64%
- 3Y
- +21.99%
- 5Y
- +14.71%
- Since Inception
- +21.45%
SIP returns (XIRR)
- 1Y
- +26.10%
- 3Y
- +16.62%
- 5Y
- +18.34%
- Since Inception
- +20.72%
Returns calculated from 12 November 2018 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 5 years (Jul 2021 – Jul 2026)
A ₹5,000 monthly SIP for the last 5 years (Jul 2021 – Jul 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹4,69,562 today — ₹3,00,000 invested, 18.4% XIRR.
₹3,00,000
Invested
₹4,69,562
Value today
18.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Jul 2021 – Jul 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹1,98,038 today (14.7% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Jul 2021 would still hold ₹15,10,818.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹4,69,562 in this fund vs ₹3,92,435 in the benchmark — outperformance of ₹77,127.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Jul 2021 – Jul 2026) (3 Jun 2024) would be ₹1,39,467 today (1.40×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised-0.04
Sharpe Ratio
+0.01
Alpha
0.24
Beta
-0.03
Sortino
13.96%
Std Dev
-16.36%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Apr 2026- Pharmaceuticals & Biotechnology65.00%
- Healthcare Services13.00%
- Insurance1.00%
- Retailing1.00%
Each sector links to the mutual funds most exposed to it.
Thinking about DSP Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with DSP Healthcare Fund - Regular Plan - IDCW
- 1Sun Pharmaceutical Industries Limited8.84%
- 2Ipca Laboratories Limited8.26%
- 3Cipla Limited7.56%
- 4Laurus Labs Limited6.42%
- 5Sai Life Sciences Limited6.10%
- 6Gland Pharma Limited5.13%
- 7Cohance Lifesciences Limited4.83%
- 8Apollo Hospitals Enterprise Limited4.73%
- 9Alembic Pharmaceuticals Limited3.43%
- 10Vijaya Diagnostic Centre Limited3.36%
Investment Objective
DSP Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
DSP Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by DSP Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹2,990 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 1.94%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations